1 |
Basik M, Aguilar-Mahecha A, Rousseau C, et al. Biopsies: nextgeneration biospecimens for tailoring therapy[J]. Nat Rev, 2013(10):437-450.
|
2 |
张佳年,计骏,刘炳亚, 等. 深低温冻存胃癌样本的核酸与蛋白质质量控制研究[J].中国肿瘤临床, 2015,43(1):27-34.
|
3 |
Grizzle WE, Gunter EW, Sexton KC, et al. Quality Management of Biorepositories[J]. Biopreserv Biobank, 2015,13(3):183-194.
|
4 |
Simeondubach D, Perren A. Better provenance for biobank samples. Nature, 2011,475(7357):454-455.
|
5 |
Ost JA, Newton PW, Neilson DR, et al. Progressive Consent and Specimen Accrual Models to Address Sustainability: A Decade′s Experience at an Oregon Biorepository[J]. Biopreserv Biobank, 2017, 15(1):3-8.
|
6 |
Kelly SM, Wiehagen LT, Schumacher PE, et al. Methods to Improve Sustainability of a Large Academic Biorepository[J]. Biopreserv Biobank, 201,15(1):31-36.
|
7 |
Tarling TE, Lasser F, Carter C, et al. Business Planning for a Campus-Wide Biobank[J]. Biopreserv Biobank, 2017,15(1):37-45.
|
8 |
Matzke LA, Babinszky S, Slotty A, et al. Biospecimen User Fees: Global Feedback on a Calculator Tool[J]. Biopreserv Biobank, 2017,15 (1):57-64.
|
9 |
Brown T, Kelly DD, Vercauteren SM, et al. How Biobanks Are Assessing and Measuring Their Financial Sustainabilit[J]. Biopreserv Biobank, 2017,15(1):65-71.
|